Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Yoshiki Kishi"'
Autor:
Mai Iwanaga, Sosei Yamaguchi, Satoshi Hashimoto, Shimpei Hanaoka, Hiroshi Kaneyuki, Kiyoshi Fujita, Yoshiki Kishi, Toyoaki Hirata, Chiyo Fujii, Naoya Sugiyama
Publikováno v:
Frontiers in Psychiatry, Vol 15 (2024)
AimsIn order to uphold and enhance the emergency psychiatric care system, a thorough comprehension of the characteristics of patients who require a high-acuity psychiatry unit is indispensable. We aimed to clarify the most important predictors of the
Externí odkaz:
https://doaj.org/article/978fe29f61774a6bb28f4470aa749311
Autor:
Yuji Higuchi, Masaki Fujiwara, Naoki Nakaya, Maiko Fujimori, Chinatsu Hayashibara, Ryuhei So, Ikuta Shinkawa, Kojiro Sato, Yuji Yada, Masafumi Kodama, Hiroshi Takenaka, Yoshiki Kishi, Kyoko Kakeda, Yosuke Uchitomi, Norihito Yamada, Masatoshi Inagaki
Publikováno v:
BMC Psychiatry, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background We performed a follow up study about willingness and behaviors to quit smoking among smokers with schizophrenia in Japan. Methods Participants were outpatients with schizophrenia aged 20–69 years who had been visiting the hospit
Externí odkaz:
https://doaj.org/article/a2bd60bac24f403a93d5a2312ffd4d19
Autor:
Sosei Yamaguchi, Yasutaka Ojio, Junko Koike, Asami Matsunaga, Makoto Ogawa, Hisateru Tachimori, Akiko Kikuchi, Hiroshi Kimura, Ataru Inagaki, Hiroyuki Watanabe, Yoshiki Kishi, Koji Yoshida, Takaaki Hirooka, Satoru Oishi, Yasuhiro Matsuda, Chiyo Fujii
Publikováno v:
International Journal of Mental Health Systems, Vol 13, Iss 1, Pp 1-11 (2019)
Abstract Background Several previous observational studies have reported the risk factors associated with readmission in people with mental illness. While patient-reported experiences and outcomes have become increasingly important in healthcare, onl
Externí odkaz:
https://doaj.org/article/7f6e5fd1ae44495694a78412c7a13a00
Autor:
Kenji, Hinotsu, Chikara, Miyaji, Yuji, Yada, Hiroki, Kawai, Shinji, Sakamoto, Yuko, Okahisa, Ko, Tsutsui, Takashi, Kanbayashi, Keiko, Tanaka, Soshi, Takao, Yoshiki, Kishi, Manabu, Takaki, Norihito, Yamada
Publikováno v:
Schizophrenia Research. 248:292-299
Anti-NMDAR encephalitis has a psychotic presentation that is difficult to distinguish from primary psychosis. An atypical psychosis that is similar to schizophrenia, mood disorder, and epilepsy is unique, and the original diagnostic criteria exist on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dee05a81b8625423465760bd817d145
https://doi.org/10.1016/j.schres.2022.08.024
https://doi.org/10.1016/j.schres.2022.08.024
Autor:
Masaru, Tsukahara, Ryuhei, So, Yuji, Yada, Masafumi, Kodama, Yoshiki, Kishi, Norihito, Yamada
Publikováno v:
Acta Medica Okayama. 76(2):137-143
Although reported for Caucasians, changes in plasma clozapine levels after smoking cessation in East Asians remain unclear. We here investigated plasma clozapine levels before and after smoking cessation in Japanese inpatients with schizophrenia. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8a724f5adca832cb661933945899b64d
https://ousar.lib.okayama-u.ac.jp/63407
https://ousar.lib.okayama-u.ac.jp/63407
Publikováno v:
Psychiatric Quarterly. 92:703-713
Slow titration of clozapine is recommended given the risk of serious adverse effects. However, the utility and safety of slower-than-recommended titration of clozapine remain unclear. Consequently, we aimed to investigate the clinical utility and saf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f532dd9c8a1bddf6d2b4e5f6f1afd1b9
https://doi.org/10.1007/s11126-020-09841-3
https://doi.org/10.1007/s11126-020-09841-3
Autor:
Hiroyoshi Takeuchi, Kenichi Tanimoto, Yasuo Fujii, Nozomi Nakajima, Yoshiki Kishi, Fuminari Misawa, Nao Mizoe, Toru Yamashita, Ryuhei So, Kohei Kitagawa
Publikováno v:
International Clinical Psychopharmacology. 36:84-88
Only a few studies have investigated changes in the dose of long-acting injectable second-generation antipsychotics (LAI-SGAs) over the long term in the maintenance treatment of schizophrenia. In this retrospective cohort study, we examined longitudi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25772949baa4e73e2d7324668a669147
https://doi.org/10.1097/yic.0000000000000347
https://doi.org/10.1097/yic.0000000000000347
Autor:
Yuto Yamada, Yoshiki Kishi, Ryuhei So, Norihito Yamada, Satoru Edahiro, Suguru Ishizu, Yukiko Matsui, Shinji Sakamoto, Masaki Fujiwara, Kiyohiro Kawada, Manabu Takaki, Keiko Kanazawa
Publikováno v:
The Journal of ECT. 36:e49-e51
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::896e4f384164a711d54a2ecde4603153
https://doi.org/10.1097/yct.0000000000000686
https://doi.org/10.1097/yct.0000000000000686
Autor:
Yoshiki Kishi, Kojiro Sato, Ryuhei So, Yuji Higuchi, Masatoshi Inagaki, Masaki Fujiwara, Yuji Yada, Maiko Fujimori, Norihito Yamada, Ikuta Shinkawa, Naoki Nakaya, Kyoko Kakeda, Yosuke Uchitomi, Masafumi Kodama, Hiroshi Takenaka, Chinatsu Hayashibara
Publikováno v:
BMC Psychiatry, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Psychiatry
BMC Psychiatry
Background We performed a follow up study about willingness and behaviors to quit smoking among smokers with schizophrenia in Japan. Methods Participants were outpatients with schizophrenia aged 20–69 years who had been visiting the hospital for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca167811997acdecfafcf0261c0581fd
http://link.springer.com/article/10.1186/s12888-019-2351-9
http://link.springer.com/article/10.1186/s12888-019-2351-9
Autor:
Namiko Matsumoto, Manabu Takaki, Soshi Takao, Yoshiki Kishi, Kota Sato, Norihito Yamada, Takashi Shibata, Shinji Sakamoto, Bunta Yoshimura, Koji Abe, Keiko Tanaka, Ko Tsutsui, Yuji Yada, Ayaka Tsuchida, Hiroki Kawai, Takashi Kanbayashi, Yuko Okahisa
Publikováno v:
European Neuropsychopharmacology. 29:1041-1050
Anti-NMDAR encephalitis is increasingly recognized as one etiology of psychiatric symptoms, but there is not enough evidence on patients with mood disorder. We assayed anti-NR1/NR2B IgG antibodies in serum and/or cerebrospinal fluid of 62 patients in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d9351aba6a41e6ee6ed19f82247e15f
https://doi.org/10.1016/j.euroneuro.2019.07.137
https://doi.org/10.1016/j.euroneuro.2019.07.137